NCT00028613View on ClinicalTrials.gov

Radiolabeled Monoclonal Antibody in Treating Patients With Previously Treated Large Cell Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

October 31, 2001

Study Completion Date

October 31, 2001

Conditions
Lymphoma
Interventions
RADIATION

iodine I 131 monoclonal antibody Lym-1

Trial Locations (1)

44106-5065

Ireland Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Case Comprehensive Cancer Center

OTHER

NCT00028613 - Radiolabeled Monoclonal Antibody in Treating Patients With Previously Treated Large Cell Lymphoma | Biotech Hunter | Biotech Hunter